
News from Pancreatic Cancer Action Network
Information about Pancreatic Cancer Action Network
Where is Pancreatic Cancer Action Network located?Pancreatic Cancer Action Network's WebsiteMedia Bias Ratings
Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top Pancreatic Cancer Action Network News

CancerPancreatic ductal adenocarcinoma (PDAC) has a poor prognosis. Although chemotherapy has become increasingly important in recent years, there are no practical markers to predict therapeutic efficacy. Here, we have aimed to identify novel markers that predict resistance to chemotherapy drugs using patient-derived organoids (PDOs) of PDAC. PDOs were established using endoscopic ultrasound - guided fine needle aspiration (EUS-FNA) specimens. Drug se…See the Story
Pancreatic Cancer Organoids Derived From EUS-Guided Fine Needle Aspiration Specimens Can Be Used to Predict Chemotherapy Resistance
100% Center coverage: 1 sources

Artificial Intelligence · MarylandJul 2, 2025 - By Charaighn SesockLOS ANGELES, CALIF. – (July 2, 2025) – The Pancreatic Cancer Action Network (PanCAN), the leading nonprofit organization dedicated to fighting pancreatic cancer, today announced a new data partnership with Acurion, a leader in AI-driven oncology diagnostics company, aimed at transforming how pancreatic cancer is sub-typed for optimal treatment selection. Using data from PanCAN’s SPARK platform and Acurion’s OncoG…Read Article
The Pancreatic Cancer Action Network Announces Partnership with Acurion to Accelerate Pancreatic Cancer Diagnostics Using AI and Real-World Patient Data
Blood test for early signs of pancreatic cancer trialled by UK doctors
58% Center coverage: 12 sources
“There Isn’t a World Where Cancer Deserves to Be Credited With Victory.”
The Current State of Federal Funding for Pancreatic Cancer Research: A Call to Action
NovoCure's Tumor Treating Fields Boost One-Year And Pain-Free Survival In Pancreatic Cancer Trial - NovoCure (NASDAQ:NVCR), Zai Lab (NASDAQ:ZLAB)
100% Center coverage: 3 sources
'Let the grief be there': Memorial Day can heighten feelings of loss; experts encourage connection and support
100% Right coverage: 2 sources